T 1306/18 (Aclidinium for the treatment of COPD / ALMIRALL) of 14.09.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T130618.20210914
- Date of decision
- 14 September 2021
- Case number
- T 1306/18
- Petition for review of
- -
- Application number
- 09719213.2
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- INHALATION COMPOSITION CONTAINING ACLIDINIUM FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
- Applicant name
- Almirall, S.A.
- Opponent name
- Hexal AG
Generics (U.K.) Limited - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54 (2007)European Patent Convention Art 56 (2007)
- Keywords
- Novelty - main request (yes)
Inventive step - main request (yes)
Inventive step - reasonable expectation of success (no) - Catchword
- -
- Cited cases
- T 1409/06
- Citing cases
- G 0002/21
Order
For these reasons it is decided that:
1. The appealed decision is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent on the basis of the main request filed with the grounds of appeal and a description to be adapted thereto.